key: cord-1051478-0zkjdegs
authors: Halamka, John; Cerrato, Paul; Perlman, Adam
title: Redesigning COVID 19 Care with Network Medicine and Machine Learning: A review
date: 2020-10-05
journal: Mayo Clin Proc Innov Qual Outcomes
DOI: 10.1016/j.mayocpiqo.2020.09.008
sha: f49649a910fb8b876c92f5daef33340a996e582e
doc_id: 1051478
cord_uid: 0zkjdegs

Emerging evidence regarding COVID 19 highlights the role of individual resistance and immune function in both susceptibility to infection as well as severity of disease. Multiple factors influence the response of the human host when exposed to viral pathogens. Influencing an individual’s susceptibility to infection include such factors as nutritional status, physical and psychosocial stressors, obesity, protein calorie malnutrition, emotional resilience, single nucleotide polymorphisms (SNPs), environmental toxins—including air pollution and first- and second-hand tobacco smoke, sleep habits, sedentary lifestyle, drug-induced nutritional deficiencies and drug-induced immunomodulatory effects, availability of nutrient dense food and empty calories. This review examines the network of interacting co-factors that influence the host-pathogen relationship, which in turn determine one’s susceptibility to viral infections like COVID 19. It then evaluates the role of machine learning, including predictive analytics and random forest modeling, to help clinicians assess patients’ risk of developing active infection and devise a comprehensive approach to prevention and treatment.

• The manuscript represents original and valid work and that neither this manuscript nor one with substantially similar content under my authorship has been published or is being considered for publication elsewhere, except as described in the cover letter submitted with the manuscript, and copies of closely related manuscripts have been provided; and • I agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity or any part of the work are appropriately investigated and resolved; and • If requested, I will provide the data or will cooperate fully in obtaining and providing the data on which the manuscript is based for examination by the editor or their assignees; and • For papers with more than 1 author, I agree to allow the corresponding author to serve as the primary correspondent with the editorial office, to review the edited manuscript and proof, and to make decisions regarding release of information in the manuscript to the media, federal agencies, or both, or, if I am the only author, I will be the corresponding author and agree to serve in the roles described above. D. To qualify for authorship, you must check at least 1 box for each of the 3 categories of contributions listed below.

I have made substantial contributions to the intellectual content of the paper as described below:

1. Check at least 1 of 2 below X conception or design X acquisition, analysis, or interpretation of data Confirm that all information provided is accurate by checking the box below and then enter your complete name as it appears at the top of this form and date of confirmation in the fields below.

X I certify that all information I have provided is accurate.

Complete Name: Paul Cerrato Date: August 28, 2020 Introduction COVID 19 continues to challenge health providers and policy makers alike. In many respects, the infection shares the features of most other viral infections. But the rapidity of its spread and its ability to nearly overwhelm health care delivery around the globe have startled many health officials and world leaders.

Public health specialists have responded to the threat, emphasizing the need for a vaccine, antiviral agents, protective equipment and social distancing. While these tactics remain top priorities, they have eclipsed a fundamental tenet of microbiology: The risk of developing any infection is determined by both the virulence of the pathogen and the resistance of the human host. Much has been written about microbial virulence, but little attention has been devoted to the factors that allow humans to resist infection. Experts have pointed to evidence to show that J o u r n a l P r e -p r o o f resistance to COVID 19 is influenced by co-existing diseases and age, but resistance is also dependent on numerous other co-factors.

The emerging field of network medicine can shed light on the interplay between microbial virulence and the ability of an individual's immune system to defend against full-blown clinical disease. Over the centuries, medicine has been dominated by a reductionistic approach to causality, a divide-and-conquer paradigm "rooted in the assumption that complex problems are solvable by dividing them into smaller, simpler, and thus more tractable units." 1 Although this methodology has generated countless rewards, it has limitations. Reductionistic thinking has led researchers to search for one or two root causes of each disease and design therapies that only address these causes. When HIV was found to cause AIDS, for instance, virtually all efforts then focused on suppressing the virus; the same has held true for many infectious disorders.

However, although HIV is undoubtedly the necessary cause of AIDS, it is not the sole and sufficient cause, as evidenced by the fact that many are exposed to the virus without contracting AIDS. These "anomalies" imply that there are cofactors that contribute to the onset of clinical disease. Detecting these entities requires the reductionist approach be complemented by network medicine, which takes a more wholistic direction, looking at a wide range of synergistic co-variates.

Network medicine examines the diverse biological systems that influence the pathogenesis of disease, rather than focusing on one or two organ systems that are typically considered for each disorder. The emergence of big data and supercomputers has given investigators insights into these networks or "nodes." And with the assistance of advanced machine-learning based algorithms, these advances are revealing new causal relationships. Joseph Loscalzo, MD, chair of medicine at Brigham and Women's Hospital, describes this paradigm shift: "With the growth of large data sets comprising detailed and comprehensive information about the genome, the transcriptome, the proteome, the metabolome, and the exposome, biomedical research has reached a stage at which specific disease-causing events can be explored and understood In To implement a network-based approach to the current pandemic, our review examines the evidence on how specific co-factors influence host-pathogen interactions, which in turn determine one's susceptibility to viral infections like COVID 19. It then evaluates the role of machine learning, including predictive analytics, to help clinicians assess patients' risk of developing active infection and to help devise a comprehensive approach to prevention and treatment.

SARS-CoV-2, the root cause of COVID 19 is a betacoronavirus that originated in bats. 3 The Center for Evidence-Base Medicine at the University of Oxford reviewed 21 analyses and found that between 5% and 80% of patients who test positive for SARS-CoV-2 may be asymptomatic. 4 The World Health Organization estimates that approximately 80% of COVID-19 positive patients experience mild to moderate signs and symptoms and do not require hospitalization. 5 Johns Hopkins University estimates that the observed case fatality rate for the infection varies from 5.9% in the United States to 16.2% in Belgium as of May 25, 2020. 6 These statistics imply that, like many other viral infections, not everyone becomes seriously ill with COVID 19. They also J o u r n a l P r e -p r o o f strongly suggest that there are co-factors that determine the impact of the virus, illustrating the complex interplay between the virus and its host.

These interactions do not readily lend themselves to the reductionistic approach. The reductionistic paradigm is ideal for deciphering the cause and the definitive treatment for many acute disorders. Ahn et al explain: "Diseases such as urinary tract infection, acute appendicitis, or aortic dissection are driven primarily by a single pathology amenable to a specific intervention.…. Reductionism works best when an isolatable problem exists and where a quick and effective solution is needed." 7 Reductionism is also effective in many simple straightforward conditions like diet-induced iron deficiency, as illustrated in Figure 1 /a. But the approach is inadequate when one attempts to understand the etiology of diseases in which the root cause is intermingled with numerous contributing co-variates that determine whether it remains asymptomatic or advances into clinical presentation.

In such circumstances, network medicine offers new insights and therapeutic options.

Essentially, this paradigm redefines health and disease, replacing the Osler approach that relies on clinicopathological correlation to postulate pathogenesis and views individual diseases as the consequences of pathological events in specific organ systems. 2 That paradigm implies that diabetes is solely a pancreatic disease, myocardial infarction is only a cardiac disease, and infections are solely the result of the presence of the infectious agent in a specific organ system. A networks approach suggests that many such disorders are systemic in origin and are the consequences of numerous metabolic, environmental and genetic factors that affect multiple organ systems. The difference between these 2 paradigms are illustrated in Similarly, there is mounting evidence to suggest that vitamin D deficiency contributes to COVID 19 infection. Investigators have found that among 212 patients with confirmed SARS-CoV-2:

"Vitamin D status is significantly associated with clinical outcomes." 10 A meta-analysis that evaluated the effects of vitamin D supplementation to prevent acute respiratory tract infections concluded: "Vitamin D supplementation was safe and it protected against acute respiratory tract infection overall." 11 Daneshkhah et al, in a yet to be peer-reviewed analysis, also found evidence that links vitamin D deficiency to COVID 19 mortality and postulate that the prohormone may suppress the cytokine storm observed in these patients. 12 Zinc is also involved in maintaining normal immune functioning, including a pivotal role in regulating signaling pathways in both innate and adaptive immune cells. 13 The trace element binds to metallothioneins, for instance, which play an important role in immune response. 14 Similarly the detrimental effects of zinc deficiency on the immune system have been welldocumented for decades, affecting approximating 2 billion persons worldwide. 13.15 To date, there is no direct evidence demonstrating that patients at risk for COVID 19 have a zinc deficit, but a lack of zinc has been shown to contribute to viral infections, including HIV infection and hepatitis C. 15 Between 8 and 11 mg of zinc 16 will prevent the clinical effects of a zinc deficiency and its impact on immune functioning. That dosage is available from a well-balanced diet, also negating the need for supplementation in most adults, with the exception of patients with an acquired malabsorption syndrome or rare genetic disorders like acrodermatitis enteropathica, the result of a mutation that encodes for a protein that binds zinc. Clinicians who are inclined to recommend zinc supplements, on the other hand, need to differentiate between the physiological effects of small doses of the nutrient and the pharmacological effect of larger doses. Once Zn-dependent enzymes are saturated, the nutrient can have unintended effects, including the displacement of copper, which explains why high doses of zinc have been shown to cause copper-deficiency induced anemia, which in itself can compromise one's ability to resist infection. 17 Numerous studies have also established a relationship between stress and immune dysfunction. In fact, the evidence linking the two has been strong enough to give birth to its own specialty: psychoneuroimmunology. Chronic stress in particular has been associated with elevated pro-inflammatory cytokines, and COVID 19 has been linked to cytokine storm. It is likely that the risk of viral infection caused by chronic stress is mediated through the hypothalamus/pituitary/adrenal axis. This pathway also contributes to the lack of J o u r n a l P r e -p r o o f responsiveness to antiviral vaccines in both mend an women who are stressed out from caring for a spouse with dementia. 18 24 The Look AHEAD study assigned over 5,000 overweight and obese patients to the lifestyle regimen or to a control group that only received supportive education. The investigators' goal was to determine if the lifestyle program would reduce the incidence of death from cardiovascular disease, non-fatal myocardial infarction, non-fatal stroke, or hospitalization for angina. The original plan was to follow these patients for as long as 13.5 years but the study was terminated early because there were no significant differences between the intervention and control groups. The lower caloric content and increased exercise in the intensive lifestyle group did help patients lose weight, but it did not reduce the rate of cardiovascular events.

Baum et al employed random forest analysis to look at 84 separate risk factors or subgroups, creating a series of 1,000 decision trees from all the available data. They used the stored J o u r n a l P r e -p r o o f characteristics of the 5,000 patients in the Look AHEAD study and divided the cohort into two halves. The first half serves as a training data set to generate hypotheses and construct the decision trees. The second half of the data served as the testing data set.

The 84 risk factors included a long list of variables including family history of diabetes, muscle cramps in legs and feet, a history of emphysema, kidney disease, amputation, dry skin, loud snoring, marital status, social functioning, hemoglobin A1c, self-reported health, and numerous other characteristics that researchers rarely consider when performing subgroup analysis. They identified co-variates that were protective and deleterious. Baum et al. discovered that intensive lifestyle modification averted cardiovascular events in two large subgroups, patients with HbA1c 6.8% or higher (poorly managed diabetes) and patients with well-controlled diabetes (Hba1c < 6.8%) and good self-reported health. That finding applied to 85% of the entire patient population studied. On the other hand, the remaining 15% who had controlled diabetes but poor self-reported general health responded negatively to the lifestyle modification regimen. The negative and positive responders cancelled each other out in the original statistical analysis conducted by the Look AHEAD investigators, which led them to falsely conclude that lifestyle modification was of no value.

A similar ML approach that includes all the known and suspected risk factors for COVID 19, including co-morbidities, genetic, metabolic and environmental variables would allow us to identify co-factors that require attention. Such actionable insights will serve as the foundation for a holistic approach to the pandemic.

Random forest modeling is only one of many ML tools that is being adapted to manage COVID 19. Mayo Clinic researchers, in partnership with nference, an AI technology company, have used a deep learning approach called nferX augmented curation 25 --------------Caption for Figures Figure 1 a,b,c, A reductionistic approach is an effective way to decipher the etiology of many simple straightforward conditions like diet-induced iron deficiency, as illustrated in Figure 1 /a. But the approach is inadequate when one attempts to understand the etiology of diseases in which the root cause is intermingled with numerous contributing co-variates that determine whether it remains asymptomatic or advances into clinical presentation. In such cases, a network medicine approach is more effective because it takes into account numerous metabolic, environmental and genetic factors that affect multiple organ systems. The differences between these 2 paradigms are illustrated in Figures 1.b and 1 c, which depict the traditional way to understand the etiology of viral infection and the networks-based approach. 

The emerging field of network medicine can shed light on the interplay between microbial virulence and the ability of an individual's immune system to defend against full-blown clinical disease.

Network medicine examines the diverse biological systems that influence the pathogenesis of disease, rather than focusing on a reductionistic approach that relies on one or two organ systems that are typically considered for each disorder.

"With the growth of large data sets comprising detailed and comprehensive information about the genome, the transcriptome, the proteome, the metabolome, and the exposome, biomedical research has reached a stage at which specific disease-causing events can be explored and understood in integrated context."

Among the specific agents that influence an individual's susceptibility to infection are nutritional status, physical and psychosocial stressors, obesity, protein calorie malnutrition, emotional resilience, single nucleotide polymorphisms (SNPs), and environmental toxinsincluding air pollution and first-and second-hand tobacco smoke.

Employing machine learning (ML) enhanced algorithms to analyze all the aforementioned risk factors and their interactions may help determine which ones predict a patient's risk of COVID 19 or the prognosis of someone who has already tested positive.

The Limits of Reductionism in Medicine: Could Systems Biology Offer an Alternative?

Network Medicine: Complex Systems in Human Disease and Therapeutics

Situation Summary

COVID-19: What proportion are asymptomatic? CEBM April 6

World Health Organization. Q and A on coronaviruses (COVID-19)

The Clinical Applications of a Systems Approach

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 -COVID-NET

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus-2019 (COVID-19)

Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data

The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients

Zinc as a Gatekeeper of Immune Function

The Role of Zinc in Antiviral Immunity

Overview of dietary trace elements. UpToDate

National Institutes of Health Office of Dietary Supplements

Zinc-Induced Copper Deficiency: A Report of Three Cases Initially Recognized on Bone Marrow Examination

Stress-induced immune dysfunction

Physical Activity, Stress, and Self-Reported Upper Respiratory Tract Infection

Moderate to Vigorous Physical Activity and Risk of Upper-Respiratory Tract Infection

Human leukocyte antigen susceptibility map for SARS-CoV-2

The landscape of host genetic factors involved in infection to common viruses and SARS-CoV-2

Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial

Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 diabetes

Augmented Curation of Unstructured Clinical Notes from a Massive EHR System Reveals Specific Phenotypic Signature of Impending COVID-19 Diagnosis

John Halamka, Paul Cerrato, and Adam Perlman have no relevant financial interests, activities, relationships, and affiliations and declare no conflicts of interest.

AGREEMENT made this 1st day of June 2016, by and between ELSEVIER INC., with offices at 50 Hampshire St., 5th Floor, Cambridge, MA 02139 (the "Publisher"), and Paul Cerrato 100 Wickham Drive Warwick, New York 10990 John Halamka 11 Unity Lane Sherborn, MA 01770 (collectively the "Author"). WHEREAS, the parties agree to the publication by the Publisher of that certain work tentatively entitled REALIZING THE PROMISE OF PRECISION MEDICINE -A FIRST EDITION OF THE ROLE OF PATIENT DATA, MOBILE TECHNOLOGY, AND CONSUMER ENGAGEMENT, as more fully described below upon the terms and conditions set forth below: 1. Manuscript Delivery a. Delivery obligations. The Author shall deliver to the Publisher on or before the 1st day of June 2017, time being of the essence, a final complete manuscript in the English language, in the format and with all deliverables noted on Annex 1 (the "Work"), in form and content consistent with the obligations noted herein and satisfactory in the Publisher's sole discretion. The Author shall retain a complete copy of all deliverables required to be delivered to the Publisher under this Agreement. b. Permissions. If the Author incorporates in the Work any material from third parties, the Author shall have procured prior to the date of manuscript delivery specified in Section 1(a), at the Author's expense, permission in writing from each copyright holder of such material to use such material in the Work consistent with the terms of the rights granted pursuant to Section 3. The Author shall fully acknowledge all previously published material in the Work. If the Author does not obtain such permissions in a timely manner or in satisfactory form, the Author shall cooperate with the Publisher in identifying substitute material and revising the Work accordingly, and the Author shall obtain the requisite substitute permissions.

Reviewer Comment: One of the challenges of such a review is the rapidly explosive availability of new information relevant to this topic. Of course, ML and AI approaches can address that. Nonetheless, such appreciated COVID infection factors, such as the relative risks of various blood types (A is higher risk, O is lower risk), did not seem to arise from the review approach. This might be related to their more recent presence in the literature.Author response. We have chosen not to include blood type as risk factor because the evidence is conflicting. Latz et al. Blood type and outcomes in patients with COVID-19 Ann Hematology. 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354354/ Reviewer Comment: The characterization of machine learning seems naïve at best. Asserting that one only need identify "a list of suspected co-variates" and then proceed with ML analyses belies the discovery challenge of that first bit. While mechanisms discussed later, such as random forest can contribute to significant feature identification, this is far from simple and often computationally demanding.Author response. We have amended the article to state that identifying suspected co-variates is more difficult than we previously suggested. We also add a discussion on the value of unsupervised ML techniques to help address the problem.Reviewer Comment BMI is actually a well established COVID risk factor at this time, there is nothing novel in such a suggestion. On the other hand, the speculative suggestions about Vitamin D and Zinc, while plausible, are made with absolutely no supporting evidence and do not materially advance the authors arguments. The discriminating predictive value around anosmia is also widely published at this point.Author Response Re BMI: Our review does not contend that BMI is a novel risk factor for COVID. The theme of our paper is that combining all the suspected and established risk factors into a predictive algorithm or risk score will allow clinicians to better determine who is more likely to develop infection or progress to more severe disease.Re Vitamin D, there is evidence. We cite Daneshkhah et al. While the data is not from an interventional trial and not yet peer reviewed, it is an observational study. Given the urgency of finding ways to manage the pandemic, and the caliber of the researchers submitting the evidence, inclusion of said report is justified.Re Zinc: We do state "To date, there is no direct evidence demonstrating that patients at risk for COVID 19 have a zinc deficit, but a lack of zinc has been shown to contribute to viral J o u r n a l P r e -p r o o f infections, including HIV infection and hepatitis C." Since our review is only suggesting possible risk factors for COVID 19, the link between zinc and other viral infections is worth including in the list of suspects.Reviewer comment:Finally, the characterization of a commercial ML product used by Mayo comes across as more advertisement than science. There is no description of methodology or contrast with the enormously capable ML methods available in R or Python.Author response: We have added another ML based solution from independent healthcare organizations so that it does not seem like we are promoting the Mayo platform.

Instructions The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in four parts.

Please enter your first and last name, and double-check the manuscript number and title.

This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work without receiving any financial support from any third party --that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". Complete the appropriate boxes to indicate the type of support and whether the payment went to you, or to your institution, or both.

This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so.For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs were provided by a pharmaceutical company, you need only list the pharmaceutical company.

Use this section to report other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what you wrote in the submitted work. 

Did you or your institution at any time receive payment or services from a third party for any aspect of the submitted work (including but not limited to grants, data monitoring board, study design, manuscript preparation, statistical analysis, etc…)? Complete each row by checking "No" or providing the requested information.J o u r n a l P r e -p r o o f